Genor Biopharma Holdings Management
Management criteria checks 2/4
Genor Biopharma Holdings' CEO is Feng Guo, appointed in Apr 2020, has a tenure of 4.25 years. total yearly compensation is CN¥24.29M, comprised of 18.5% salary and 81.5% bonuses, including company stock and options. directly owns 1.15% of the company’s shares, worth €767.42K. The average tenure of the management team and the board of directors is 3.9 years and 2.6 years respectively.
Key information
Feng Guo
Chief executive officer
CN¥24.3m
Total compensation
CEO salary percentage | 18.5% |
CEO tenure | 4.3yrs |
CEO ownership | 1.2% |
Management average tenure | 3.9yrs |
Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | CN¥24m | CN¥5m | -CN¥674m |
Sep 30 2023 | n/a | n/a | -CN¥637m |
Jun 30 2023 | n/a | n/a | -CN¥599m |
Mar 31 2023 | n/a | n/a | -CN¥665m |
Dec 31 2022 | CN¥32m | CN¥5m | -CN¥730m |
Sep 30 2022 | n/a | n/a | -CN¥800m |
Jun 30 2022 | n/a | n/a | -CN¥870m |
Mar 31 2022 | n/a | n/a | -CN¥868m |
Dec 31 2021 | CN¥41m | CN¥5m | -CN¥865m |
Compensation vs Market: Feng's total compensation ($USD3.34M) is above average for companies of similar size in the German market ($USD525.52K).
Compensation vs Earnings: Feng's compensation has been consistent with company performance over the past year.
CEO
Feng Guo (54 yo)
4.3yrs
Tenure
CN¥24,285,000
Compensation
Dr. Feng Guo Ph D., serves as Chairman of the Board for Genor BioPharma Co., Ltd. since November 2021.He serves as Chairman at Genor Biopharma Holdings Limited since November 02, 2021. Dr. Guo has been th...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 4.3yrs | CN¥24.29m | 1.15% CN¥ 767.4k | |
Vice President of Finance | no data | no data | no data | |
Chief Technology Officer | 2.8yrs | no data | no data | |
Chief Scientist | 3.5yrs | no data | no data | |
Vice President of Compliance & Administration | no data | no data | no data | |
Chief Medical Officer | 3.9yrs | no data | no data | |
Company Secretary | 2.1yrs | no data | no data | |
Vice President of Quality Analysis | 4.5yrs | no data | no data | |
General Manager of Yuxi Genor | 4.9yrs | no data | no data |
3.9yrs
Average Tenure
54.5yo
Average Age
Experienced Management: 67N0's management team is considered experienced (3.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 4.3yrs | CN¥24.29m | 1.15% CN¥ 767.4k | |
Member of Scientific Advisory Board | 2.6yrs | no data | no data | |
Member of Scientific Advisory Board | 2.6yrs | no data | no data | |
Independent Non-Executive Director | 4.1yrs | CN¥420.00k | no data | |
Member of Scientific Advisory Board | 2.6yrs | no data | no data | |
Independent Non-Executive Director | 4.1yrs | CN¥420.00k | no data | |
Independent Non-Executive Director | 3.8yrs | CN¥420.00k | no data | |
Non Executive Director | 2.7yrs | no data | no data | |
Chairman of Scientific Advisory Board | 3.2yrs | no data | no data | |
Member of Scientific Advisory Board | 2.6yrs | no data | no data | |
Member of Scientific Advisory Board | 2.6yrs | no data | no data | |
Member of Scientific Advisory Board | 2.6yrs | no data | no data |
2.6yrs
Average Tenure
57.5yo
Average Age
Experienced Board: 67N0's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.